DOCHERTY JOHN MARTIN 4
4 · Lexaria Bioscience Corp. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
- Purchase
common shares
2025-07-29$0.93/sh+5,376$4,989→ 5,376 total
Holdings
- 36,334
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (18,334 underlying) - 51,334
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying) - 111,334
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (30,000 underlying) - 160,834
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (49,500 underlying) - 18,000
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (18,000 underlying) - 54,075(indirect: Private Holding Company)
common shares
- 81,334
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying) - 310,834
Stock Options
Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (150,000 underlying)